CNO Financial Group Inc

CNO remains in a Stage 2 uptrend with a clear series of higher highs and higher lows. The recent pullback into rising 20-day and 50-day EMAs around the 54 5 zone offers a tactical entry in an otherwise bullish structural context. Short-term momentum is constructive and RSI is neutral, supporting a Buy Now stance despite Bullish Exhaustion signals at the highs.

• ↑Q2 2026 operating EPS $1.26 (+45% YoY) with 16th straight quarter of sales growth
• ↑Full-year operating EPS guidance upped to $4.60–$4.80, underscoring strong middle-income demand
• ↓Increased MedSupp claims risk compressing underwriting margins